Señales en vivo de VYNT | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 dic 2023 @ 15:39):

Stats
Volumen de hoy	19 116.00
Volumen promedio	17 863.00
Capitalización de mercado	1.23M
EPS	$0 ( 2024-03-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0721
ATR14	$0.00900 (4.64%)

Insider Trading

Date	Person	Action	Amount	type
2021-11-09	Hansen Paul R.	Buy	6 783	Common Stock, $0.0001 par value
2023-01-17	Hansen Paul R.	Buy	4 032	Common Stock, $0.0001 par value
2023-01-17	Harris Geoffrey E.	Buy	5 712	Common Stock, $0.0001 par value
2023-01-17	Fletcher R John	Buy	4 368	Common Stock, $0.0001 par value
2023-01-17	Horobin Joanna	Buy	7 526	Common Stock, $0.0001 par value

INSIDER POWER
98.15
Last 98 transactions
Buy: 5 441 265 \| Sell: 193 337

Volumen Correlación

Largo: -0.14 (neutral)

Corto: 0.17 (neutral)

Signal:(69.635) Neutral

Cancer Genetics Inc Correlación

10 Correlaciones Más Positivas
BOCH	0.893
SHSP	0.855

10 Correlaciones Más Negativas
TDAC	-0.958
GAINL	-0.9
APOP	-0.882
RMRM	-0.838
NTEC	-0.825
ISNS	-0.814
CMLF	-0.802

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cancer Genetics Inc Correlación - Moneda/Commodity

0.26
( neutral )

0.32
( neutral )

0.00
( neutral )

0.13
( neutral )

-0.87
( strong negative )

-0.20
( neutral )

Cancer Genetics Inc Finanzas

Annual	2022
Ingresos:	$666 000
Beneficio Bruto:	$-342 000 (-51.35 %)
EPS:	$-3.87

FY	2022
Ingresos:	$666 000
Beneficio Bruto:	$-342 000 (-51.35 %)
EPS:	$-3.87

FY	2021
Ingresos:	$1.15M
Beneficio Bruto:	$-699 000 (-60.89 %)
EPS:	$-9.03

FY	2020
Ingresos:	$867 000
Beneficio Bruto:	$-234 000 (-26.99 %)
EPS:	$-1.492

Financial Reports:

No articles found.

Cancer Genetics Inc

Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). Vyant Bio, Inc. has a collaboration agreement to discover drugs for the treatment of Parkinson's Disease. The company is based in Cherry Hill, New Jersey.